112 results
8-K
PYXS
Pyxis Oncology Inc
12 Jun 24
Submission of Matters to a Vote of Security Holders
4:17pm
: Ratification of Appointment of Independent Registered Public Accounting Firm
The stockholders ratified the appointment of Ernst & Young LLP … as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 by the following vote:
For
Against
Abstain
Broker
8-K
PYXS
Pyxis Oncology Inc
10 Jun 24
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
7:56am
(the “Board”). The Board has determined that Mr. Metzger qualifies as an independent director under the corporate governance standards of The Nasdaq
DEFA14A
PYXS
Pyxis Oncology Inc
26 Apr 24
Additional proxy soliciting materials
4:16pm
Flavin 1.03 Lara Sullivan,M.D. 1.04 Jakob Dupont,M.D. 2. The ratification of the appointment of Ernst & Young LLP as our independent registered public
424B2
2ybon5h0bfn243a307
3 Apr 24
Prospectus for primary offering
8:45pm
8-K
9ink0 rtkpf9
13 Mar 24
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
4:31pm
8-K
EX-4.1
qy5b0si
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.2
v1jx6 g3m
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
71b1xorsq520so
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K/A
EX-99.1
4qgrh8pcb evkov
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-23.1
xwtxgfszt
27 Oct 23
Index to Consolidated Financial Statements
4:34pm